Yu Qiu

Yu Qiu is an experienced professional in antibody engineering and multi-specific biologics modeling and design, currently serving as the Executive Director of Biologics Design and Technology at AstraZeneca. Previously, they were a Postdoctoral Fellow at St. Jude Children's Research Hospital, where they conducted structural studies of enzymes involved in autophagy. Yu also worked as a Senior Scientist at Sanofi from 2017 to 2020 and holds a Bachelor's degree in Chemistry and a Ph.D. in Structural Biology from the University of Science and Technology of China. Their goal is to design first-in-class and best-in-class biologics that empower patients' lives.